RWHAP Part B and ADAP Succession Planning Guide
Resource updated 09/19/2023
Resource updated 09/19/2023
Resource updated 04/16/2024
Resource updated 09/18/2023
Resource updated 09/19/2023
Resource from the RWHAP Best Practices Compilation updated on 11/13/2023
Blog updated 03/28/2024
Resource updated 03/23/2023
Resource updated 04/03/2024
Resource updated 04/03/2024
In a single-center restrospective cohort study, patients with extensive treatment experience and history of virologic failure and multi-drug resistance underwent simplification of ARV salvage regimens with a median pill burden reduction of six pills per day. This strategy led to high rates of virologic suppression.
Resource (Conference Presentation) updated 09/14/2023
The first long-acting injectable antiretroviral therapy (LAI ART) formulation was FDA-approved January 2021. Drawing on the Consolidated Framework on Implementation Research, this mixed methods study assessed knowledge, attitudes, practices, and perceived barriers and facilitators related to implementation of LAI ART in NYC among HIV clinic staff and people with HIV.
Resource (Conference Presentation) updated 09/14/2023
The role of nurses in identifying and addressing social determinants of health in order to enhance viral suppression among people with HIV.
Resource (Conference Presentation) updated 09/14/2023
This presentation will share innovative strategies in the creation of a reflective Consumer Advisory Board, HIT HIV. The presentation will showcase quality improvement projects the HIT HIV CAB completed while leveraging technology, social media, consumer feedback, and CQM principles ensuring a community-driven and equitable process toward ending the HIV epidemic.
Resource (Conference Presentation) updated 09/14/2023
This session will share findings from the 2021 National Ending the HIV Epidemic (EHE) TA Implementation Meeting. The meeting provided increased opportunities for alignment and showcased disruptively innovative components forecasting future needs and highlighting EHE TA/CBA providers.
Resource (Conference Presentation) updated 09/14/2023
California’s AIDS Drug Assistance Program (ADAP) and Pre-Exposure Prophylaxis Assistance Program (PrEP-AP) provide access to life-saving medications and insurance assistance for eligible California residents living with or at risk of acquiring HIV. This presentation will explore the efficacy of various program policy changes implemented by California during the COVID-19 pandemic.
Resource (Conference Presentation) updated 09/14/2023